Cent Eur J Public Health 2011, 19(4):217-221 | DOI: 10.21101/cejph.a3628

Risk Factors of Hepatitis C Infection among Egyptian Blood Donors

Hala Ibrahim Awadalla1, Mostafa Hassan Ragab1, Nozat Ahmed Nassar3, Mahmoud Abd Hamid Osman2
1 Institute of Environmental Studies and Research, Ain Shams University, Cairo, Egypt
2 Faculty of Medicine, Ain Shams University, Cairo, Egypt
3 Faculty of Medicine, Cairo University, Cairo, Egypt

Background: Surveillance of infectious disease markers in the blood donor population is important in recognizing trends in prevalence and incidence of transfusion related infections in asymptomatic volunteer blood donors.

Subjects and Methods: It was a cross sectional study. Samples were collected from volunteer blood donors and questionnaire was designed to collect the risk factors data. The prevalence of hepatitis C antibodies among 1,000 apparently healthy blood donors were determined.

Objective: To estimate the prevalence of virus C hepatic infection and to illustrate the various socio-economic, behavioural and medical factors related to infection with Hepatitis C (HCV) among apparently healthy individuals. It contributed to analysis of the particularities of Egyptian blood donors and helped to better understand the challenges and solutions of blood safety.

Results: The prevalence of HCV was 16.8%. There was an association of positive anti-HCV test with socio-demographic, medical and behavioural risk factors.

Conclusion: This study provided comprehensive and reliable information on the possible risk factors affecting spread of Hepatitis C in the area.

Keywords: HCV, risk factors, blood

Received: June 7, 2010; Revised: August 12, 2011; Accepted: August 12, 2011; Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Awadalla HI, Ragab MH, Nassar NA, Osman MAH. Risk Factors of Hepatitis C Infection among Egyptian Blood Donors. Cent Eur J Public Health. 2011;19(4):217-221. doi: 10.21101/cejph.a3628. PubMed PMID: 22432397.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14757-62. Go to original source... Go to PubMed...
    2. Glynn SA, Kleinman SH, Wright DJ, Busch MP; NHLBI Retrovirus Epidemiology Donor Study. International application of the incidence rate/window period model. Transfusion. 2002 Aug;42(8):966-72. Go to original source...
    3. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec. 1999 Dec 10;74(49):425-7. Go to PubMed...
    4. Merkinaite S, Lazarus JV, Gore C.Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Public Health. 2008 Sep;16(3):106-10. Go to original source...
    5. Alam MM, Zaidi SZ, Malik SA, Naeem A, Shaukat S, Sharif S, et al. Serology based disease status of Pakistani population infected with hepatitis B virus. BMC Infect Dis. 2007 Jun 27;7:64. Go to original source... Go to PubMed...
    6. Lee HC, Ko NY, Lee NY, Chang CM, Ko WC. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc. 2008 May;107(5):404-11. Go to original source... Go to PubMed...
    7. Pépin J, Lavoie M, Pybus OG, Pouillot R, Foupouapouognigni Y, Rousset D, et al. Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis. 2010 Oct 1;51(7):768-76. Go to original source... Go to PubMed...
    8. Maieron A, Metz-Gercek S, Hackl F, Luger C, Ziachehabi A, Strauss R, et al. Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveill. 2010 Feb 25;15(8):19492. Go to original source... Go to PubMed...
    9. Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):147-54. Go to PubMed...
    10. Sosa-Jurado F, Santos-López G, Guzmán-Flores B, Ruiz-Conde JI, Meléndez-Mena D, Vargas-Maldonado MT, et al. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. Virol J. 2010 Jan 25;7:18. Go to original source... Go to PubMed...
    11. Wang JE. A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med. 1995 Dec;17(4):387-91.
    12. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA. 2000 Jul 12;284(2):229-35. Go to original source...
    13. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, AlHamdan S, et al. Prevalence of viral markers among first-timeArab blood donors in Kuwait. Transfusion. 2005 Dec;45(12):1973-80. Go to original source... Go to PubMed...
    14. Tripathi AK, Khanna M, Gupta N, Chandra M. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. J Assoc Physicians India. 2007 Jun;55:429-31. Go to PubMed...
    15. Halim AB, Garry RF, Dash S, Gerber MA. Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg. 1999 Jun;60(6):915-20. Go to original source...
    16. Klenerman P, Lucas M, Barnes E, Harcourt G. Immunity to hepatitis C virus: stunned but not defeated. Microbes Infect. 2002 Jan;4(1):57-65. Go to original source... Go to PubMed...
    17. Mostafa A, Taylor SM, el-Daly M, el-Hoseiny M, Bakr I, Arafa N, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int. 2010 Apr;30(4):560-6. Go to original source... Go to PubMed...
    18. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996 Jun 27;334(26):1685-90. Go to original source... Go to PubMed...
    19. van der Poel CL. Hepatitis C virus and blood transfusion: past and present risks. J Hepatol. 1999;31 Suppl 1:101-6. Go to original source... Go to PubMed...
    20. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol. 1999;31 Suppl 1:3-8. Go to PubMed...
    21. Alberti A, Boccato S, Vario A, Benvegnù L. Therapy of acute hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S195-200. Go to original source... Go to PubMed...

    Return to the content